Business Areas
Connected Healthcare Capabilities, Built for Market Access
KTD operates across diagnostics, regenerative medicine, aesthetic medicine, and advanced biopharma—connecting scientific understanding with regulatory navigation, commercialization, and long-term market development in Iran.
Four business areas, one connected platform
KTD operates across four connected healthcare business areas. Each area combines scientific understanding, regulatory navigation, commercial execution, and access to professional healthcare networks—adapted to the product, its evidence, and the realities of the Iranian market.
KTD’s role differs by product and by owner. Some products are manufactured by partner companies and distributed by KTD; some technologies are owned or developed by KTD; and some programs remain investigational or under development.
Together, the four areas form one coherent market-access platform rather than four unrelated businesses.
-
Distributed by KTD
Products manufactured by partner companies—such as Hemostica or Cell Tech Biogenesis—and brought to the Iranian market through KTD distribution.
-
Owned or developed by KTD
Technologies and systems owned or developed by KTD and commercialized under KTD responsibility.
-
Investigational & research programs
Clinical-development and research programs that are not approved treatments and are not commercially available.
Business Area 01
Diagnostics
Laboratory solutions spanning coagulation testing, quality control, analyzer support, and related diagnostic workflows.
-
Coagulation Reagents
Thromboplastin Reagent
A laboratory reagent designed for prothrombin time testing and evaluation of the extrinsic and common coagulation pathways in citrated plasma.
Manufactured by Hemostica · Distributed by KTD
-
Coagulation Reagents
Cephalin EA
An activated partial thromboplastin time reagent developed for laboratory assessment of the intrinsic and common coagulation pathways.
Manufactured by Hemostica · Distributed by KTD
-
Coagulation Reagents
Fibrinogen Reagent
A functional coagulation reagent intended for quantitative determination of fibrinogen concentration in citrated plasma.
Manufactured by Hemostica · Distributed by KTD
-
Quality Controls
Normal Hemostasis Control
Quality-control plasma designed to monitor the performance and consistency of routine coagulation assays within the normal analytical range.
Manufactured by Hemostica · Distributed by KTD
-
Analyzer Consumables
Coagulation Cuvettes and Stirring Components
Laboratory consumables designed to support controlled reaction handling and clot-detection workflows in compatible coagulation analyzers.
Manufactured by Hemostica · Distributed by KTD
Business Area 02
Regenerative Medicine
Professional systems and supportive technologies for platelet-rich plasma preparation, autologous applications, tissue processing, wound care, and recovery-oriented workflows.
-
PRP Systems
Alpha PRP Kit — General Use
A sterile preparation system for obtaining platelet-rich plasma for approved professional regenerative and aesthetic applications.
Manufactured by Cell Tech Biogenesis · Distributed by KTD
-
Autologous Plasma Gel
EZ-GEL Biofiller System
A programmable benchtop system designed to apply controlled heating cycles during the standardized preparation of autologous plasma gel for professional regenerative and aesthetic applications.
Developed by KTD · Distributed by KTD
-
Adipose-Tissue Processing
SVF-PREP Blade System
A multi-stage mechanical adipose-tissue processing system featuring interchangeable blade sizes for controlled tissue refinement within approved professional workflows.
Developed by KTD · Distributed by KTD
-
Advanced Wound Care
Alpha-Heal Hydrogel
A moisture-supporting wound-care hydrogel designed to help maintain a favorable local environment for wound management and tissue-repair processes.
Manufactured by Cell Tech Biogenesis · Distributed by KTD
-
Advanced Wound Care
Alpha-Heal Sponge Dressing
A porous absorbent wound dressing developed to manage exudate and support an appropriately moist wound environment.
Manufactured by Cell Tech Biogenesis · Distributed by KTD
-
Nutritional Recovery Support
HEAL-NUTRI Wound Healing Support
A nutritional-support formulation combining selected nutritional ingredients to support needs associated with tissue repair and recovery.
Developed by KTD · Distributed by KTD
Business Area 03
Aesthetic Medicine
Professional aesthetic solutions centered on regenerative approaches, post-procedure support, and controlled autologous preparation workflows.
-
Post-Procedure Care
GF Repair Mask
A two-component post-procedure facial-care system combining a sheet mask with an active serum to support hydration, comfort, and recovery following suitable professional aesthetic procedures.
Developed by KTD · Distributed by KTD
-
PRP Systems
Alpha PRP Kit — General Use
A sterile preparation system for obtaining platelet-rich plasma for approved professional regenerative and aesthetic applications.
Manufactured by Cell Tech Biogenesis · Distributed by KTD
-
Autologous Plasma Gel
EZ-GEL Biofiller System
A programmable benchtop system designed to apply controlled heating cycles during the standardized preparation of autologous plasma gel for professional regenerative and aesthetic applications.
Developed by KTD · Distributed by KTD
Business Area 04
Advanced Biopharma & Research
A development-focused area for translational research, precision-oncology platforms, and investigational cell-therapy programs.
-
Cell Therapy Clinical Development
NK Cell Therapy Program
- Investigational — Phase II Clinical Trial
- Not commercially available
An investigational natural killer cell-therapy program currently in a Phase II clinical trial. Not commercially available.
Developed by KTD
-
Cell Therapy Clinical Development
Mesenchymal Stromal Cell Therapy Program
- Investigational — Phase I Clinical Trial
- Not commercially available
An investigational mesenchymal stromal cell-therapy program currently in a Phase I clinical trial. Not commercially available.
Developed by KTD
-
Precision Oncology Platforms
Tumor Modeling & Chemosensitivity Evaluation Platform
- Research & Development
- Not currently offered
A research-stage tumor-modeling platform under development for comparative evaluation of tumor response to anticancer therapies. Not currently offered as a clinical diagnostic service.
Developed by KTD
Programs in this area are investigational or under development. They are not approved treatments, are not in routine clinical use, and are not commercially available.
Integration
One Market-Access Platform Across Multiple Healthcare Domains
KTD brings each business area into a shared operating model that connects evidence, regulatory requirements, market structure, professional engagement, and commercial execution.
-
Scientific Evaluation
Every area begins with understanding the technology, its evidence, and its clinical context before market decisions are made.
-
Regulatory Navigation
Registration pathways and documentation requirements are assessed for each product category and market context.
-
Market Access
Products reach the market through the channels, institutions, and professional networks appropriate to their area.
-
Commercial Development
Positioning, launch preparation, and market development are managed as disciplined, long-term programs.
-
Professional Education and Support
Healthcare communities receive scientific and technical engagement appropriate to each product and specialty.
-
Long-Term Partnership Development
Manufacturers work with KTD through structured, transparent partnerships that extend beyond initial market entry.
Looking to Enter or Expand in the Iranian Healthcare Market?
KTD works with healthcare manufacturers and technology developers seeking scientifically grounded, regulation-aware, and commercially disciplined market development.